San Diego-primarily based Viking Therapeutics marked itself as a significant competitor within the weight loss drug industry in February just after revealing promising knowledge from the mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection and in Mar… Read More